Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


10.12.2018

1 Acad Radiol
2 Biomark Med
1 Biosens Bioelectron
2 Cancer
1 Cancers (Basel)
1 Cell Prolif
1 Clin Rehabil
3 Eur Urol
1 Front Oncol
1 Front Pharmacol
1 Int Arch Occup Environ Health
1 Int Braz J Urol
1 Int J Cancer
1 Int J Mol Sci
1 Int J Urol
2 J Cancer
1 J Med Imaging Radiat Sci
1 J Sci Food Agric
2 Lancet Oncol
2 Neoplasma
1 Proc Natl Acad Sci U S A
1 Saudi J Biol Sci
2 Transl Androl Urol
2 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acad Radiol

  1. LI H, Liu L, Ding L, Zhang Z, et al
    Quantitative Assessment of Bladder Cancer Reflects Grade and Recurrence: Comparing of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging.
    Acad Radiol. 2018 Nov 29. pii: S1076-6332(18)30480.
    PubMed     Text format     Abstract available


    Biomark Med

  2. NEKOOHESH L, Modarressi MH, Mowla SJ, Sadroddiny E, et al
    Expression profile of miRNAs in urine samples of bladder cancer patients.
    Biomark Med. 2018 Dec 3. doi: 10.2217/bmm-2018-0190.
    PubMed     Text format     Abstract available

  3. ZHANG WT, Zhang ZW, Guo YD, Wang LS, et al
    Discovering biomarkers in bladder cancer by metabolomics.
    Biomark Med. 2018 Dec 3. doi: 10.2217/bmm-2018-0229.
    PubMed     Text format     Abstract available


    Biosens Bioelectron

  4. PENG C, Hua MY, Li NS, Hsu YP, et al
    A colorimetric immunosensor based on self-linkable dual-nanozyme for ultrasensitive bladder cancer diagnosis and prognosis monitoring.
    Biosens Bioelectron. 2018;126:581-589.
    PubMed     Text format     Abstract available


    Cancer

  5. BRYAN RT
    Association between treatment of superficial bladder cancer and 10-year mortality in older adults with multiple chronic conditions.
    Cancer. 2018 Dec 5. doi: 10.1002/cncr.31888.
    PubMed     Text format    

  6. GARG T, Young AJ, O'Keeffe-Rosetti M, McMullen CK, et al
    Reply to Association between treatment of superficial bladder cancer and 10-year mortality in older adults with multiple chronic conditions.
    Cancer. 2018 Dec 5. doi: 10.1002/cncr.31894.
    PubMed     Text format    


    Cancers (Basel)

  7. IDE H, Inoue S, Miyamoto H
    The Role of Glucocorticoid Receptor Signaling in Bladder Cancer Progression.
    Cancers (Basel). 2018;10.
    PubMed     Text format     Abstract available


    Cell Prolif

  8. YANG J, Wang B, Chen H, Chen X, et al
    Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway.
    Cell Prolif. 2018 Dec 4:e12560. doi: 10.1111/cpr.12560.
    PubMed     Text format     Abstract available


    Clin Rehabil

  9. RAMMANT E, Fonteyne V, Decaestecker K, Bultijnck R, et al
    Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy: a qualitative interview study.
    Clin Rehabil. 2018 Dec 4:269215518815531. doi: 10.1177/0269215518815531.
    PubMed     Text format     Abstract available


    Eur Urol

  10. MOSCHINI M, Zaffuto E, Mattei A, Karakiewicz PI, et al
    Reply to Nicholas G. Zaorsky, Daniel E. Spratt, and Pierre Blanchard's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical
    Eur Urol. 2018 Nov 29. pii: S0302-2838(18)30941.
    PubMed     Text format    

  11. FIORENTINO A, Errico A, Scarcia M
    Re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol
    Eur Urol. 2018 Nov 27. pii: S0302-2838(18)30881.
    PubMed     Text format    

  12. MOSCHINI M, Zaffuto E, Mattei A, Karakiewicz PI, et al
    Reply to Alba Fiorentino, Angelo Errico, and Marcello Scarcia's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostat
    Eur Urol. 2018 Nov 30. pii: S0302-2838(18)30942.
    PubMed     Text format    


    Front Oncol

  13. DEL BENE G, Calabro F, Giannarelli D, Plimack ER, et al
    Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database.
    Front Oncol. 2018;8:463.
    PubMed     Text format     Abstract available


    Front Pharmacol

  14. ROSENKRANZ AA, Slastnikova TA, Karmakova TA, Vorontsova MS, et al
    Antitumor Activity of Auger Electron Emitter (111)In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression.
    Front Pharmacol. 2018;9:1331.
    PubMed     Text format     Abstract available


    Int Arch Occup Environ Health

  15. SCIANNAMEO V, Carta A, d'Errico A, Giraudo MT, et al
    New insights on occupational exposure and bladder cancer risk: a pooled analysis of two Italian case-control studies.
    Int Arch Occup Environ Health. 2018 Nov 30. pii: 10.1007/s00420-018-1388.
    PubMed     Text format     Abstract available


    Int Braz J Urol

  16. MORGAN TN, Turner RM II, Baptiste J, Lyon TD, et al
    Small cell bladder cancer: should we consider prophylactic cranial irradiation?
    Int Braz J Urol. 2018;44.
    PubMed     Text format     Abstract available


    Int J Cancer

  17. GE Q, Lu M, Ju L, Qian K, et al
    miR-4324-RACGAP1-STAT3-ESR1 feedback loop inhibits proliferation and metastasis of bladder cancer.
    Int J Cancer. 2018 Dec 3. doi: 10.1002/ijc.32036.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  18. ECKE TH, Weiss S, Stephan C, Hallmann S, et al
    UBC((R)) Rapid Test-A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-Study.
    Int J Mol Sci. 2018;19.
    PubMed     Text format     Abstract available


    Int J Urol

  19. NAKATA W, Yamamichi G, Tsujimura G, Tsujimoto Y, et al
    Impact of serum sodium concentration on survival outcomes in patients with invasive bladder cancer without metastasis treated by cystectomy.
    Int J Urol. 2018 Dec 2. doi: 10.1111/iju.13880.
    PubMed     Text format    


    J Cancer

  20. FERRO M, Di Lorenzo G, Buonerba C, Lucarelli G, et al
    Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer.
    J Cancer. 2018;9:4250-4254.
    PubMed     Text format     Abstract available

  21. ZHANG X, Shi X, Li J, Mo L, et al
    PD-1 Blockade Overcomes Adaptive Immune Resistance in Treatment with Anchored-GM-CSF Bladder Cancer Cells Vaccine.
    J Cancer. 2018;9:4374-4381.
    PubMed     Text format     Abstract available


    J Med Imaging Radiat Sci

  22. CHEN S, Kong V, Craig T, Chung P, et al
    Efficient and Effective Personalization of PTV Margins During Radiation Therapy for Bladder Cancer.
    J Med Imaging Radiat Sci. 2018;49:420-427.
    PubMed     Text format     Abstract available


    J Sci Food Agric

  23. CHANG WJ, Chen BH, Inbaraj BS, Chien JT, et al
    Preparation of allyl isothiocyanate nanoparticles, their anti-inflammatory activity towards RAW 264.7 macrophage cells and anti-proliferative effect on HT1376 bladder cancer cells.
    J Sci Food Agric. 2018 Dec 5. doi: 10.1002/jsfa.9524.
    PubMed     Text format     Abstract available


    Lancet Oncol

  24. GOURD E
    Neoadjuvant pembrolizumab in bladder cancer.
    Lancet Oncol. 2018;19:e669.
    PubMed     Text format    

  25. MIYAMOTO DT, Mouw KW, Feng FY, Shipley WU, et al
    Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer.
    Lancet Oncol. 2018;19:e683-e695.
    PubMed     Text format     Abstract available


    Neoplasma

  26. CHI BJ, Zhao DM, Liu L, Yin XZ, et al
    Downregulation of hsa_circ_0000285 serves as a prognostic biomarker for bladder cancer and is involved in cisplatin resistance.
    Neoplasma. 2018 Sep 16. pii: 180318N185. doi: 10.4149/neo_2018_180318.
    PubMed     Text format     Abstract available

  27. NA XY, Shang XS, Zhao Y, Ren PP, et al
    MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4.
    Neoplasma. 2018 Sep 29. pii: 180512N312. doi: 10.4149/neo_2018_180512.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  28. SOKOLOV I, Dokukin ME, Kalaparthi V, Miljkovic M, et al
    Noninvasive diagnostic imaging using machine-learning analysis of nanoresolution images of cell surfaces: Detection of bladder cancer.
    Proc Natl Acad Sci U S A. 2018 Dec 3. pii: 1816459115.
    PubMed     Text format     Abstract available


    Saudi J Biol Sci

  29. YANG Y, Liu K, Yang L, Zhang G, et al
    Bladder cancer cell viability inhibition and apoptosis induction by baicalein through targeting the expression of anti-apoptotic genes.
    Saudi J Biol Sci. 2018;25:1478-1482.
    PubMed     Text format     Abstract available


    Transl Androl Urol

  30. PEYTON CC, Azizi M, Sexton WJ
    Understanding risk and refining surveillance following tumor resection for low grade non-muscle invasive bladder cancer.
    Transl Androl Urol. 2018;7:987-989.
    PubMed     Text format    

  31. MIYAKE M, Fujimoto K
    Pretreatment assessment and perioperative nutritional interventions for patients with bladder cancer undergoing radical cystectomy.
    Transl Androl Urol. 2018;7:984-986.
    PubMed     Text format    


    World J Urol

  32. WERNTZ RP, Adamic B, Steinberg GD
    Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC).
    World J Urol. 2018 Dec 4. pii: 10.1007/s00345-018-2592.
    PubMed     Text format     Abstract available

  33. HU G, Xu F, Zhong K, Wang S, et al
    The prognostic role of preoperative circulating neutrophil-lymphocyte ratio in primary bladder cancer patients undergoing radical cystectomy: a meta-analysis.
    World J Urol. 2018 Dec 3. pii: 10.1007/s00345-018-2593.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: